Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Future Science OA
|
December 24, 2025
Why are we still missing the pain? Rethinking diabetic neuropathy in primary care - lessons from the REGENERAR study
Antonio Alcántara Montero
Pain
|
May 13, 2025
Pain in functional gastrointestinal disorders: nociplastic pain or something else?
Antonio Alcántara Montero
Medicina Clinica
|
November 8, 2024
Paradigm change in the management of benign prostatic hyperplasia
Antonio Alcántara Montero
British Journal of Anaesthesia
|
October 10, 2025
Targeting Na<sub>v</sub>1.8 with the nonopioid antagonist suzetrigine in analgesia. Comment on Br J Anaesth 2025; 135: 829-32
Antonio Alcántara Montero
European Journal of Pain (London, England)
|
October 13, 2025
Mirogabalin: Promising Evidence, Uncertain Access
Antonio Alcántara Montero
Diabetes & Metabolism Journal
|
November 17, 2025
On a Phenotypic Approach to Diabetic Peripheral Neuropathy (Diabetes Metab J 2025;49:542-64)
Antonio Alcántara Montero
British Journal of Pain
|
March 5, 2026
Reflections on suzetrigine and the evolving landscape of non-opioid analgesia
Antonio Alcántara Montero
CNS Drugs
|
April 5, 2026
Is Crisugabalin Signaling the Arrival of a Third Generation of α2δ Ligands?
Antonio Alcántara Montero
Pain
|
May 14, 2026
Towards a unified paradigm: chronic pain and functional somatic disorders
Antonio Alcántara Montero
BMJ Evidence-Based Medicine
|
October 29, 2025
Reconsidering the role of tramadol in chronic pain management
Antonio Alcántara Montero
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Future Science OA
|
December 24, 2025
Why are we still missing the pain? Rethinking diabetic neuropathy in primary care - lessons from the REGENERAR study
Antonio Alcántara Montero
Pain
|
May 13, 2025
Pain in functional gastrointestinal disorders: nociplastic pain or something else?
Antonio Alcántara Montero
Medicina Clinica
|
November 8, 2024
Paradigm change in the management of benign prostatic hyperplasia
Antonio Alcántara Montero
British Journal of Anaesthesia
|
October 10, 2025
Targeting Na<sub>v</sub>1.8 with the nonopioid antagonist suzetrigine in analgesia. Comment on Br J Anaesth 2025; 135: 829-32
Antonio Alcántara Montero
European Journal of Pain (London, England)
|
October 13, 2025
Mirogabalin: Promising Evidence, Uncertain Access
Antonio Alcántara Montero
Diabetes & Metabolism Journal
|
November 17, 2025
On a Phenotypic Approach to Diabetic Peripheral Neuropathy (Diabetes Metab J 2025;49:542-64)
Antonio Alcántara Montero
British Journal of Pain
|
March 5, 2026
Reflections on suzetrigine and the evolving landscape of non-opioid analgesia
Antonio Alcántara Montero
CNS Drugs
|
April 5, 2026
Is Crisugabalin Signaling the Arrival of a Third Generation of α2δ Ligands?
Antonio Alcántara Montero
Pain
|
May 14, 2026
Towards a unified paradigm: chronic pain and functional somatic disorders
Antonio Alcántara Montero
BMJ Evidence-Based Medicine
|
October 29, 2025
Reconsidering the role of tramadol in chronic pain management
Antonio Alcántara Montero
Page
of 7